ObjectiveTo determine risk factors of medical adherence and describe strategies to increase adherence in patients with chronic rhinologic disease.Data SourcesPubMED, SCOPUS, CINAHL, and Cochrane.Review MethodsSystematic review of 4 databases (PubMED, SCOPUS, CINAHL, Cochrane) from inception of databases to September 1, 2022 to identify studies that evaluated factors related to and affected by medical adherence in patients with chronic rhinologic disease.ResultsOf 1491 studies screened, 25 studies met inclusion criteria. Of these, 7 studies described how sensory attributes of intranasal sprays affect adherence, including odor, taste, aftertaste, and side effects. Five studies described record keeping diaries/notification systems to improve adherence, with demonstration of web‐based platforms to send reminders as well as keep record of medication usage to improve adherence. Eight studies described patient‐specific risk factors to nonadherence, with demonstration of increased age and conscientious personalities correlating with medical adherence. Five studies looked at pediatric patients specifically, with adherence rates in children parallelling that of adults. Additionally, nonadherence in children may have greater implications for school performance.ConclusionOverall, adherence to topical medical therapy in patients with chronic rhinologic disease is affected by patient‐related and medication‐specific factors which should be considered when counseling patients. Web‐based diary or notification systems may help increase adherence. Additionally, children are equally adherent to topical medical therapy as adults and nonadherence may have negative implications for school performance.